glp 1 drugs alzheimer's Alzheimer's: Ozempic and Similar May Help Decrease Dementia Risk GLP-1 Drugs and Brain Health:

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis.

Popular weight loss drugs like Ozempic and Wegovy may cut the risk of Alzheimers disease and other forms of dementia, a large new analysis found

Deal Snapshot: Novo is partnering with Ascendis on less frequently dosed drugs for metabolic diseases, committing up to $285m for a lead program, a once-monthly GLP-1 receptor agonist.

ICD-10 codes to identify the outcome are included in supplementary table S1

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.

The oral version must be taken in a special way - it should be taken after fasting overnight, with a small amount of water (no more than half a cup)